Redfield RR - Search Results

1

Expansion of restricted cellular immune responses to HIV-1 envelope by vaccination: IL-7 and IL-12 differentially augment cellular proliferative responses to HIV-1.

Kim JH, Loveland JE, Sitz KV, Ratto Kim S, Mclinden RJ, Tencer K, Davis K, Burke DS, Boswell RN, Redfield RR, Birx DL. Kim JH, et al. Among authors: redfield rr. Clin Exp Immunol. 1997 May;108(2):243-50. doi: 10.1046/j.1365-2249.1997.d01-1006.x. Clin Exp Immunol. 1997. PMID: 9158092 Free PMC article. Clinical Trial.

2

HIV vaccine therapy.

Birx DL, Redfield RR. Birx DL, et al. Among authors: redfield rr. Int J Immunopharmacol. 1991;13 Suppl 1:129-32. doi: 10.1016/0192-0561(91)90134-s. Int J Immunopharmacol. 1991. PMID: 1823904

3

Humoral responses to linear epitopes on the HIV-1 envelope in seropositive volunteers after vaccine therapy with rgp160.

Loomis LD, Deal CD, Kersey KS, Burke DS, Redfield RR, Birx DL. Loomis LD, et al. Among authors: redfield rr. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Sep 1;10(1):13-26. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7544225

4

Lack of induction of antibodies specific for conserved, discontinuous epitopes of HIV-1 envelope glycoprotein by candidate AIDS vaccines.

VanCott TC, Bethke FR, Burke DS, Redfield RR, Birx DL. VanCott TC, et al. Among authors: redfield rr. J Immunol. 1995 Oct 15;155(8):4100-10. J Immunol. 1995. PMID: 7561123

5

Consequences of stable transduction and antigen-inducible expression of the human interleukin-7 gene on tetanus-toxoid-specific T cells.

Kim JH, Ratto S, Sitz KV, Mosca JD, McLinden RJ, Tencer KL, Vahey MT, St Louis D, Birx DL, Redfield RR. Kim JH, et al. Among authors: redfield rr. Hum Gene Ther. 1994 Dec;5(12):1457-66. doi: 10.1089/hum.1994.5.12-1457. Hum Gene Ther. 1994. PMID: 7711138

6

Establishment and characterization of human immunodeficiency virus type 1 (HIV-1) envelope-specific CD4+ T lymphocyte lines from HIV-1-seropositive patients.

Ratto S, Sitz KV, Scherer AM, Manca F, Loomis LD, Cox JH, Redfield RR, Birx DL. Ratto S, et al. Among authors: redfield rr. J Infect Dis. 1995 Jun;171(6):1420-30. doi: 10.1093/infdis/171.6.1420. J Infect Dis. 1995. PMID: 7769275 Clinical Trial.

7

Immunization of HIV-infected patients with rgp160: modulation of anti-rgp120 antibody spectrotype.

Biselli R, Loomis LD, Del Bono V, Burke DS, Redfield RR, Birx DL. Biselli R, et al. Among authors: redfield rr. J Acquir Immune Defic Syndr (1988). 1994 Oct;7(10):1016-24. J Acquir Immune Defic Syndr (1988). 1994. PMID: 8083819 Clinical Trial.

8

Immunotherapeutic strategies in the treatment of HIV infection and AIDS.

Birx DL, Redfield RR. Birx DL, et al. Among authors: redfield rr. Curr Opin Immunol. 1993 Aug;5(4):600-7. doi: 10.1016/0952-7915(93)90044-s. Curr Opin Immunol. 1993. PMID: 8216935 Review.

9

V3 seroreactivity and sequence variation: tracking the emergence of V3 genotypic variation in HIV-1-infected patients.

Michael NL, Davis KE, Loomis-Price LD, VanCott TC, Burke DS, Redfield RR, Birx DL. Michael NL, et al. Among authors: redfield rr. AIDS. 1996 Feb;10(2):121-9. doi: 10.1097/00002030-199602000-00001. AIDS. 1996. PMID: 8838699 Clinical Trial.

10

Repeated immunization with recombinant gp160 human immunodeficiency virus (HIV) envelope protein in early HIV-1 infection: evaluation of the T cell proliferative response.

Ratto-Kim S, Sitz KV, Garner RP, Kim JH, Davis C, Aronson N, Ruiz N, Tencer K, Redfield RR, Birx DL. Ratto-Kim S, et al. Among authors: redfield rr. J Infect Dis. 1999 Feb;179(2):337-44. doi: 10.1086/314587. J Infect Dis. 1999. PMID: 9878016 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

330 results

Search Page

Filters